Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)
JavaScript is disabled for your browser. Some features of this site may not work without it.
Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA)
Oksuzoglu, B.; Benekli, M.; Ozaslan, E.; Cicin, I.; Ozkan, M.; Karaoglu, A.; Dane, F.; Cubukcu, E.; Elkiran, E. T.; Aliustaoglu, M.; Sevinc, A.; Isikdogan, A.; Kocer, M.